Paracetamol/opioid analgesic controlled-release - Medtronic/Depomed

Drug Profile

Paracetamol/opioid analgesic controlled-release - Medtronic/Depomed

Alternative Names: Acetaminophen/opioid analgesic controlled-release - Covidien/Depomed

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Covidien; Depomed
  • Developer Medtronic
  • Class Acetanilides; Non-opioid analgesics; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid receptor agonists; Prostaglandin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Pain

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Pain in USA (PO, Controlled release)
  • 30 Nov 2011 Covidien initiates a Phase-I trial of a second controlled-release paracetamol/opioid analgesic product for Pain in USA
  • 28 Sep 2010 Phase-I clinical trials in Pain in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top